We are delighted to see the positive traction in our weight management efforts, which has more than doubled the revenue run-rate of our primary care business since the pilot launch." LifeMD sets itself apart as a leading provider of primary care, prioritizing the overall health and well-being of patients, rather than solely focusing on weight loss," said Dr
Please use the form below and one of our associates will get in touch with you shortly.
The GLP-1 resulted in 5.8% weight loss after four weeks of treatment in type 2 diabetes patients
pmid:7641412 Li Y, Teng D, Shan Z, et al
Precision is also paramount in terms of getting optimal treatment for people, and the appeal of different treatments might differ amongst people. GLP-1 Treatments Face Hurdles While GLP-1s offer promising benefits for some patients, significant barriers remain regarding supply, cost, and insurance coveragechallenges that Saunders describes as humongous limitations. Novo Nordisks Ozempic and Wegovy have been on the FDAs drug shortage list since 2022